COVAX
Registro de marca em vigor (Madri)
Marca Nominativa depositada no INPI em
16/09/2021 por GAVI Alliance,
processo nº 501629954, nas classes 35, 36, 41.
Registro em vigor até 16/09/2031.
| Número do processo | 501629954 |
|---|
| Situação | Registro de marca em vigor (Madri) |
|---|
| Apresentação | Nominativa |
|---|
| Natureza | Madri
Produto/Serviço |
|---|
| Data do depósito | 16/09/2021 |
|---|
| Data da concessão | 31/10/2023 |
|---|
| Vigência até | 16/09/2031 |
|---|
| Titular | GAVI Alliance |
|---|
| CNPJ/CPF do titular | — |
|---|
| UF · País | — · CH |
Classes e especificação
Advertising services, namely, public advocacy for promoting public awareness of public health issues, vaccine benefits, vaccine hesitancy, the health risks of an under-immunized community, and equitable access to vaccines; advertising to promote public awareness of public health issues, the benefits of vaccines, vaccine hesitancy, the health risks of an under-immunized community, and equitable access to vaccines; procurement services for others, namely, purchase of vaccines.;
Charitable fundraising services, namely, fundraising and distribution of donations for the purchase and supply of medical goods and services; financial services, namely, investment of funds for research, development, manufacturing and distribution of vaccines; insurance services, namely, settlement of civil liability claims; claims processing in the field of insurance, namely, processing settlement claims and insurance authorization information and support.;
Publication of texts and magazines, videos and articles in the field of public health, vaccine benefits, vaccine hesitancy, the health risks of an under-immunized community, and equitable access to vaccines; education, namely, providing training and seminars in the field of vaccines and medicines; organization of educational and informational meetings and conferences in the field of vaccines and medicines; providing information in the field of public health, vaccine benefits, vaccine hesitancy, the health risks of an under-immunized community, and equitable access to vaccines via an online website.;